Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05081154 · ClinicalTrials.gov registry record · NA
CSD201002: Study to Assess Nicotine Uptake From P10 Nicotine Pouches
A NA study, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT05081154 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 36 participants.
The verdict
NCT05081154, a NA study, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study is a single-center, open-label, randomized, 7-way crossover study designed to evaluate plasma nicotine pharmacokinetics (PK) parameters following use of the study investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (CC) smokers.
Interventions
- OTHER Product A
- OTHER Product B
- OTHER Product C
- OTHER Product D
- OTHER Product E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-10-20 |
| Est. Completion | 2021-11-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05081154
The ClinicalTrials.gov registry entry for NCT05081154 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Product A is the first listed.
NCT05081154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05081154 about?
NCT05081154 is a clinical study titled "CSD201002: Study to Assess Nicotine Uptake From P10 Nicotine Pouches". This study is a single-center, open-label, randomized, 7-way crossover study designed to evaluate plasma nicotine pharmacokinetics (PK) parameters following use of the study investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (CC) smokers.
What is the current status of trial NCT05081154?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-10-20. Estimated completion is 2021-11-24.
What interventions are being tested in trial NCT05081154?
The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product E (OTHER).
Who is sponsoring clinical trial NCT05081154?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.